COMP <GO>
GOSS vs CPIX // ENTERPRISE SCALE & MARKET CAP
Gossamer Bio Inc. (NASDAQ) VS. Cumberland Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: GOSS 2
— CPIX 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: GOSS
LAST: $10.38 (-2.90%) • MKT CAP: $65.4M
market-cap
$65.4M
LAST: $4.69 (+7.82%) • MKT CAP: $65.2M
market-cap
$65.2M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GOSS VS. CPIX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GOSS | CPIX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 85.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -16.40% | -18.60 | CPIX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 7.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -6.30% | -53.70 | CPIX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -6.40% | -53.60 | CPIX | /net-margins <GO> |
| Revenue Growth (YoY) | -57.70% | 17.60% | -75.30 | CPIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.72 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 7/9 | -6.00 | CPIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.3 | 35.3 | +16.07 | GOSS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $65.4M | $65.2M | $207.7K | GOSS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GOSS REV | CPIX REV | GOSS GROSS % | CPIX GROSS % | GOSS FCF | CPIX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $48.5M | $44.5M | — | 85.0% | -$171.3M | $4.8M |
| FY 2024 | $114.7M | $37.9M | — | 82.6% | -$3.5M | -$678.6K |
| FY 2023 | $0 | $39.6M | — | — | -$159.2M | $6.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GOSS // BETA —
CPIX // BETA —